Global /China /Healthcare /Drug Manufacturers - Specialty & Generic /2877
chevron_leftBack
China Shineway Pharmaceutical Group Ltd. logo

China Shineway Pharmaceutical Group Ltd.

2877
SHEK: 2877 Delayed
9.71HKD -1.4%
1.24 USD
As of 6 June 2026, China Shineway Pharmaceutical Group Ltd. has a market cap of $949.65M USD, ranking #11006 globally and #3126 in China. It ranks #993 in the Healthcare sector, and #51 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
11006
Country Rank
3126
Sector Rank
993
Industry Rank
51
Key Stats
Market Cap
$949.65MUSD
7.44B HKD
Enterprise Value
-$78.13MUSD
-612.23M HKD
Revenue (TTM)
$445.31MUSD
3.49B HKD
EBITDA (TTM)
$105.03MUSD
822.95M HKD
Net Income (TTM)
$134.92MUSD
1.06B HKD
EBITDA Margin
24%
Profit Margin
30%
PE Ratio
7.0
Forward PE
6.8
PS Ratio
2.1
PB Ratio
0.8
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
2,867
Founded
2002
Website
shineway.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-1.4% -2.5% 7.1% 4.2% 17% 27%

News

Loading...

Markets

Exchange Ticker Price
Hong Kong Stock Exchange
MIC: XHKG
PRIMARY
2877
中国神威药业集团有限公司
ISIN: KYG2110P1000
Shares Out.:
755.4M1 Shares Float: 254.513M2
TV:
SA:
YF:
GF:
BA:
MS:
9.71 HKD
Frankfurt Stock Exchange
MIC: XFRA
C1S
中国神威药业集团有限公司
ISIN: KYG2110P1000
TV:
SA:
YF:
GF:
BA:
C1S
MS:
1.05 EUR
OTC Markets
MIC: OTCM
CSWYY
中国神威药业集团有限公司 ADR
ISIN: US16947J1007
TV:
SA:
YF:
GF:
BA:
MS:
19.25 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About China Shineway Pharmaceutical Group Ltd.

China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong. The company offers Chinese medicines in the form of injection, soft capsules, and granules; tablets, pills, oral liquid, and powder; and traditional Chinese medicine granules in various therapeutic areas, including respiratory system disease, nervous system, digestive system disease, cardiovascular and cerebrovascular, orthopedics, pediatrics, and other areas, as well as medication for strengthening the body. It is also involved in the trading of agricultural products. The company was incorporated in 2002 and is headquartered in Shijiazhuang, China. China Shineway Pharmaceutical Group Limited is a subsidiary of Forway Investment Limited.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (China)
Name
Market Cap diff.
PE
$15.86B
107.34B CNY
2K%
16.0
$9.1B
61.6B CNY
858%
80.6
$5.22B
35.33B CNY
450%
20.0
$4.21B
28.47B CNY
343%
20.8
$3.27B
22.12B CNY
244%
8.1
$2.74B
18.55B CNY
189%
11.5
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
PE
$37.66B
108.92B ILS
4K%
24.2
$29.56B
3K%
-
CIPLA
$11.12B
1.06T INR
1K%
23.4
LUPIN
$11.0B
1.05T INR
1K%
22.7
$8.79B
7.57B EUR
825%
-
AUROPHARMA
$8.43B
807.02B INR
788%
23.1
chevron_leftBack